Shareholder Information

ExpreS2ion Biotech Holding AB (company reg. no. 559033-3729) is the Swedish limited liability company listed on Nasdaq First North Growth Market since 2016. ExpreS2ion Biotechnologies ApS (CVR No. 32 77 04 87) is the Danish operational entity, with offices and labs in the Scion DTU Science park just North of Copenhagen, and is 100% owned by ExpreS2ion Biotech Holding AB. ExpreS2ion Biotech is listed on NASDAQ First North Growth Market with ticker symbol EXPRS2. Link to EXPRS2 at NASDAQ web-page here.

List of largest shareholders

Name Number of shares held Share of votes and capital
ExpreS2ion Holding ApS1 1.744.370 10,66%
AR Consult ApS2 1.306.109 7,98%
Summary shareholders over 5% 3.050.479 18,64%
Remaining shareholders (below 5%) 13.315.412 81,36%
Total 30/09/2020 16.365.891 100,00%

1. Chairman of the board Martin Roland Jensen holds 32.2 percent of the capital and votes in ExpreS2ion Holding ApS. Charlotte Dyring, a co-founder of the Company, owns 39.2 percent of the capital and votes in ExpreS2ion Holding ApS. CSO Wian de Jongh owns 28.6 percent of the capital and votes in ExpreS2ion Holding ApS.

2. Board member Allan Rosetzsky owns 100% of the shares in AR Consult ApS.

Certified Advisor

Svensk Kapitalmarknadsgranskning AB

Email: ca@skmg.se

Phone: +46 11 32 30 732

Web: www.skmg.se